We focus exclusively on the healthcare sector—working with biotech, pharmaceutical, and medical technology companies aiming to expand internationally.

Our core focus is on emerging markets, particularly the Middle East, the Balkans, and North Africa. We provide deep regional insight and on-the-ground support.

No. While many of our clients are U.S.-based, we also support companies from the Middle East and other global regions looking to expand their international presence.

We offer a hands-on, execution-driven model. Beyond strategy, we actively facilitate partnerships, navigate regulations, and support implementation—acting as an outsourced international expansion team.

Timelines vary by region and regulatory complexity, but most projects range from 3 to 12 months from initial assessment to launch support.

Timelines vary by region and regulatory complexity, but most projects range from 3 to 12 months from initial assessment to launch support.

Yes. We specialize in helping U.S. startups build early-stage international strategies, including market validation, regulatory planning, and identifying the right entry points for future expansion.

We provide end-to-end support—from customizing market entry strategies and navigating foreign regulations to securing trusted local partners—acting as your outsourced international expansion team.